nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2C9—brain cancer	0.632	1	CbGaD
Diphenhydramine—CYP2D6—Lomustine—brain cancer	0.0669	0.271	CbGbCtD
Diphenhydramine—CYP1A2—Carmustine—brain cancer	0.0662	0.268	CbGbCtD
Diphenhydramine—CYP2D6—Hydroxyurea—brain cancer	0.0507	0.205	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—brain cancer	0.0439	0.178	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—brain cancer	0.0196	0.0793	CbGbCtD
Diphenhydramine—HRH1—nose—brain cancer	0.00208	0.163	CbGeAlD
Diphenhydramine—Photosensitivity—Procarbazine—brain cancer	0.00151	0.0205	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Procarbazine—brain cancer	0.00147	0.02	CcSEcCtD
Diphenhydramine—Diplopia—Procarbazine—brain cancer	0.00132	0.018	CcSEcCtD
Diphenhydramine—Sweating increased—Procarbazine—brain cancer	0.00111	0.0152	CcSEcCtD
Diphenhydramine—Pollakiuria—Procarbazine—brain cancer	0.00106	0.0144	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Procarbazine—brain cancer	0.00104	0.0142	CcSEcCtD
Diphenhydramine—Drowsiness—Procarbazine—brain cancer	0.00102	0.0139	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Lomustine—brain cancer	0.001	0.0137	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Procarbazine—brain cancer	0.001	0.0136	CcSEcCtD
Diphenhydramine—SLC22A1—ganglion—brain cancer	0.000999	0.0784	CbGeAlD
Diphenhydramine—Chest discomfort—Etoposide—brain cancer	0.000997	0.0136	CcSEcCtD
Diphenhydramine—Anorexia—Lomustine—brain cancer	0.000977	0.0133	CcSEcCtD
Diphenhydramine—Decreased appetite—Lomustine—brain cancer	0.000891	0.0121	CcSEcCtD
Diphenhydramine—Nasal congestion—Temozolomide—brain cancer	0.000878	0.012	CcSEcCtD
Diphenhydramine—Diplopia—Carmustine—brain cancer	0.000828	0.0113	CcSEcCtD
Diphenhydramine—Dysuria—Hydroxyurea—brain cancer	0.000828	0.0113	CcSEcCtD
Diphenhydramine—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000824	0.0289	CbGpPWpGaD
Diphenhydramine—Chills—Procarbazine—brain cancer	0.000821	0.0112	CcSEcCtD
Diphenhydramine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000808	0.0284	CbGpPWpGaD
Diphenhydramine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000804	0.0282	CbGpPWpGaD
Diphenhydramine—Diplopia—Temozolomide—brain cancer	0.0008	0.0109	CcSEcCtD
Diphenhydramine—Drowsiness—Hydroxyurea—brain cancer	0.000789	0.0107	CcSEcCtD
Diphenhydramine—Tension—Procarbazine—brain cancer	0.000782	0.0106	CcSEcCtD
Diphenhydramine—Nervousness—Procarbazine—brain cancer	0.000774	0.0105	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000774	0.0105	CcSEcCtD
Diphenhydramine—Tremor—Procarbazine—brain cancer	0.000747	0.0102	CcSEcCtD
Diphenhydramine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000721	0.0253	CbGpPWpGaD
Diphenhydramine—Convulsion—Procarbazine—brain cancer	0.00069	0.0094	CcSEcCtD
Diphenhydramine—Sweating increased—Temozolomide—brain cancer	0.000674	0.00917	CcSEcCtD
Diphenhydramine—Dry mouth—Procarbazine—brain cancer	0.000664	0.00903	CcSEcCtD
Diphenhydramine—Confusional state—Procarbazine—brain cancer	0.000656	0.00893	CcSEcCtD
Diphenhydramine—Vomiting—Lomustine—brain cancer	0.000651	0.00887	CcSEcCtD
Diphenhydramine—Dysuria—Temozolomide—brain cancer	0.000647	0.0088	CcSEcCtD
Diphenhydramine—Pollakiuria—Temozolomide—brain cancer	0.000639	0.00869	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Procarbazine—brain cancer	0.000637	0.00867	CcSEcCtD
Diphenhydramine—Chills—Hydroxyurea—brain cancer	0.000636	0.00865	CcSEcCtD
Diphenhydramine—Tachycardia—Procarbazine—brain cancer	0.000635	0.00864	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Temozolomide—brain cancer	0.000631	0.00859	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Procarbazine—brain cancer	0.000629	0.00856	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Carmustine—brain cancer	0.000625	0.00851	CcSEcCtD
Diphenhydramine—Anorexia—Procarbazine—brain cancer	0.00062	0.00844	CcSEcCtD
Diphenhydramine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000609	0.0214	CbGpPWpGaD
Diphenhydramine—Nausea—Lomustine—brain cancer	0.000609	0.00828	CcSEcCtD
Diphenhydramine—Hypotension—Procarbazine—brain cancer	0.000608	0.00827	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000604	0.00823	CcSEcCtD
Diphenhydramine—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000601	0.0211	CbGpPWpGaD
Diphenhydramine—Insomnia—Procarbazine—brain cancer	0.000588	0.00801	CcSEcCtD
Diphenhydramine—Paraesthesia—Procarbazine—brain cancer	0.000584	0.00795	CcSEcCtD
Diphenhydramine—Somnolence—Procarbazine—brain cancer	0.000578	0.00787	CcSEcCtD
Diphenhydramine—Oxaprozin—CYP2C9—brain cancer	0.000577	0.103	CrCbGaD
Diphenhydramine—Decreased appetite—Procarbazine—brain cancer	0.000565	0.0077	CcSEcCtD
Diphenhydramine—Fatigue—Procarbazine—brain cancer	0.000561	0.00763	CcSEcCtD
Diphenhydramine—Constipation—Procarbazine—brain cancer	0.000556	0.00757	CcSEcCtD
Diphenhydramine—PTGS1—ganglion—brain cancer	0.000545	0.0428	CbGeAlD
Diphenhydramine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000544	0.0191	CbGpPWpGaD
Diphenhydramine—Sweating increased—Etoposide—brain cancer	0.000539	0.00734	CcSEcCtD
Diphenhydramine—Feeling abnormal—Procarbazine—brain cancer	0.000536	0.0073	CcSEcCtD
Diphenhydramine—Convulsion—Hydroxyurea—brain cancer	0.000534	0.00727	CcSEcCtD
Diphenhydramine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000524	0.0184	CbGpPWpGaD
Diphenhydramine—Urticaria—Procarbazine—brain cancer	0.000517	0.00703	CcSEcCtD
Diphenhydramine—Tinnitus—Temozolomide—brain cancer	0.000516	0.00702	CcSEcCtD
Diphenhydramine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000501	0.0176	CbGpPWpGaD
Diphenhydramine—Chills—Temozolomide—brain cancer	0.000497	0.00676	CcSEcCtD
Diphenhydramine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000495	0.0174	CbGpPWpGaD
Diphenhydramine—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000493	0.0173	CbGpPWpGaD
Diphenhydramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000493	0.00671	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Etoposide—brain cancer	0.000484	0.00658	CcSEcCtD
Diphenhydramine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000482	0.0169	CbGpPWpGaD
Diphenhydramine—Anorexia—Hydroxyurea—brain cancer	0.00048	0.00653	CcSEcCtD
Diphenhydramine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000471	0.0166	CbGpPWpGaD
Diphenhydramine—PTGS1—endothelium—brain cancer	0.00047	0.0369	CbGeAlD
Diphenhydramine—Vision blurred—Carmustine—brain cancer	0.00047	0.0064	CcSEcCtD
Diphenhydramine—Tremor—Carmustine—brain cancer	0.000467	0.00636	CcSEcCtD
Diphenhydramine—Asthenia—Procarbazine—brain cancer	0.000467	0.00635	CcSEcCtD
Diphenhydramine—Agranulocytosis—Etoposide—brain cancer	0.00046	0.00627	CcSEcCtD
Diphenhydramine—Agitation—Carmustine—brain cancer	0.000458	0.00624	CcSEcCtD
Diphenhydramine—Vision blurred—Temozolomide—brain cancer	0.000454	0.00618	CcSEcCtD
Diphenhydramine—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000454	0.0159	CbGpPWpGaD
Diphenhydramine—Tremor—Temozolomide—brain cancer	0.000451	0.00614	CcSEcCtD
Diphenhydramine—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.000451	0.0158	CbGpPWpGaD
Diphenhydramine—Somnolence—Hydroxyurea—brain cancer	0.000447	0.00609	CcSEcCtD
Diphenhydramine—Diarrhoea—Procarbazine—brain cancer	0.000445	0.00606	CcSEcCtD
Diphenhydramine—Dyspepsia—Hydroxyurea—brain cancer	0.000443	0.00603	CcSEcCtD
Diphenhydramine—Agitation—Temozolomide—brain cancer	0.000443	0.00603	CcSEcCtD
Diphenhydramine—CYP2C18—endocrine gland—brain cancer	0.000441	0.0346	CbGeAlD
Diphenhydramine—Decreased appetite—Hydroxyurea—brain cancer	0.000438	0.00596	CcSEcCtD
Diphenhydramine—Fatigue—Hydroxyurea—brain cancer	0.000434	0.00591	CcSEcCtD
Diphenhydramine—PTGS1—blood vessel—brain cancer	0.000434	0.034	CbGeAlD
Diphenhydramine—Vertigo—Temozolomide—brain cancer	0.000433	0.00589	CcSEcCtD
Diphenhydramine—Convulsion—Carmustine—brain cancer	0.000432	0.00588	CcSEcCtD
Diphenhydramine—Constipation—Hydroxyurea—brain cancer	0.00043	0.00586	CcSEcCtD
Diphenhydramine—Dizziness—Procarbazine—brain cancer	0.00043	0.00585	CcSEcCtD
Diphenhydramine—Palpitations—Temozolomide—brain cancer	0.000426	0.0058	CcSEcCtD
Diphenhydramine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000424	0.0149	CbGpPWpGaD
Diphenhydramine—Cyclizine—CYP2C9—brain cancer	0.000424	0.0758	CrCbGaD
Diphenhydramine—Convulsion—Temozolomide—brain cancer	0.000417	0.00568	CcSEcCtD
Diphenhydramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000415	0.00565	CcSEcCtD
Diphenhydramine—Vomiting—Procarbazine—brain cancer	0.000414	0.00563	CcSEcCtD
Diphenhydramine—Phenprocoumon—CYP2C9—brain cancer	0.000411	0.0736	CrCbGaD
Diphenhydramine—Confusional state—Carmustine—brain cancer	0.00041	0.00558	CcSEcCtD
Diphenhydramine—Rash—Procarbazine—brain cancer	0.00041	0.00558	CcSEcCtD
Diphenhydramine—Dermatitis—Procarbazine—brain cancer	0.00041	0.00558	CcSEcCtD
Diphenhydramine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000408	0.0143	CbGpPWpGaD
Diphenhydramine—Headache—Procarbazine—brain cancer	0.000407	0.00555	CcSEcCtD
Diphenhydramine—Dry mouth—Temozolomide—brain cancer	0.000401	0.00546	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Carmustine—brain cancer	0.000398	0.00542	CcSEcCtD
Diphenhydramine—Chills—Etoposide—brain cancer	0.000397	0.00541	CcSEcCtD
Diphenhydramine—Tachycardia—Carmustine—brain cancer	0.000397	0.00541	CcSEcCtD
Diphenhydramine—Confusional state—Temozolomide—brain cancer	0.000397	0.0054	CcSEcCtD
Diphenhydramine—CHRM2—telencephalon—brain cancer	0.000393	0.0308	CbGeAlD
Diphenhydramine—Anorexia—Carmustine—brain cancer	0.000388	0.00528	CcSEcCtD
Diphenhydramine—Nausea—Procarbazine—brain cancer	0.000386	0.00526	CcSEcCtD
Diphenhydramine—SLC22A1—telencephalon—brain cancer	0.000386	0.0302	CbGeAlD
Diphenhydramine—Thrombocytopenia—Temozolomide—brain cancer	0.000385	0.00524	CcSEcCtD
Diphenhydramine—Phenylbutazone—CYP2C9—brain cancer	0.000382	0.0683	CrCbGaD
Diphenhydramine—Hypotension—Carmustine—brain cancer	0.00038	0.00518	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Temozolomide—brain cancer	0.00038	0.00517	CcSEcCtD
Diphenhydramine—Anorexia—Temozolomide—brain cancer	0.000375	0.0051	CcSEcCtD
Diphenhydramine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000374	0.0131	CbGpPWpGaD
Diphenhydramine—Insomnia—Carmustine—brain cancer	0.000368	0.00501	CcSEcCtD
Diphenhydramine—Paraesthesia—Carmustine—brain cancer	0.000365	0.00497	CcSEcCtD
Diphenhydramine—Warfarin—CYP2C9—brain cancer	0.000365	0.0653	CrCbGaD
Diphenhydramine—Somnolence—Carmustine—brain cancer	0.000362	0.00492	CcSEcCtD
Diphenhydramine—Asthenia—Hydroxyurea—brain cancer	0.000361	0.00492	CcSEcCtD
Diphenhydramine—Carbinoxamine—CYP2C9—brain cancer	0.00036	0.0644	CrCbGaD
Diphenhydramine—Insomnia—Temozolomide—brain cancer	0.000356	0.00484	CcSEcCtD
Diphenhydramine—Decreased appetite—Carmustine—brain cancer	0.000354	0.00481	CcSEcCtD
Diphenhydramine—Paraesthesia—Temozolomide—brain cancer	0.000353	0.00481	CcSEcCtD
Diphenhydramine—Somnolence—Temozolomide—brain cancer	0.00035	0.00476	CcSEcCtD
Diphenhydramine—Constipation—Carmustine—brain cancer	0.000348	0.00474	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—brain cancer	0.000346	0.00471	CcSEcCtD
Diphenhydramine—Dyspepsia—Temozolomide—brain cancer	0.000346	0.00471	CcSEcCtD
Diphenhydramine—Diarrhoea—Hydroxyurea—brain cancer	0.000344	0.00469	CcSEcCtD
Diphenhydramine—Decreased appetite—Temozolomide—brain cancer	0.000342	0.00465	CcSEcCtD
Diphenhydramine—CYP2D6—hindbrain—brain cancer	0.00034	0.0267	CbGeAlD
Diphenhydramine—Fatigue—Temozolomide—brain cancer	0.000339	0.00461	CcSEcCtD
Diphenhydramine—Constipation—Temozolomide—brain cancer	0.000336	0.00458	CcSEcCtD
Diphenhydramine—Feeling abnormal—Carmustine—brain cancer	0.000335	0.00456	CcSEcCtD
Diphenhydramine—Convulsion—Etoposide—brain cancer	0.000334	0.00455	CcSEcCtD
Diphenhydramine—Dizziness—Hydroxyurea—brain cancer	0.000333	0.00453	CcSEcCtD
Diphenhydramine—Feeling abnormal—Temozolomide—brain cancer	0.000324	0.00441	CcSEcCtD
Diphenhydramine—Vomiting—Hydroxyurea—brain cancer	0.00032	0.00436	CcSEcCtD
Diphenhydramine—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000318	0.0112	CbGpPWpGaD
Diphenhydramine—Rash—Hydroxyurea—brain cancer	0.000317	0.00432	CcSEcCtD
Diphenhydramine—Confusional state—Etoposide—brain cancer	0.000317	0.00432	CcSEcCtD
Diphenhydramine—Dermatitis—Hydroxyurea—brain cancer	0.000317	0.00432	CcSEcCtD
Diphenhydramine—Headache—Hydroxyurea—brain cancer	0.000315	0.00429	CcSEcCtD
Diphenhydramine—Urticaria—Temozolomide—brain cancer	0.000312	0.00425	CcSEcCtD
Diphenhydramine—Brompheniramine—CYP2C9—brain cancer	0.000312	0.0558	CrCbGaD
Diphenhydramine—Thrombocytopenia—Etoposide—brain cancer	0.000308	0.00419	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—brain cancer	0.000307	0.00418	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—brain cancer	0.000304	0.00414	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—brain cancer	0.0003	0.00408	CcSEcCtD
Diphenhydramine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000299	0.0105	CbGpPWpGaD
Diphenhydramine—Nausea—Hydroxyurea—brain cancer	0.000299	0.00407	CcSEcCtD
Diphenhydramine—Modafinil—CYP2C9—brain cancer	0.000299	0.0535	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP2C9—brain cancer	0.000296	0.0529	CrCbGaD
Diphenhydramine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000295	0.0104	CbGpPWpGaD
Diphenhydramine—Hypotension—Etoposide—brain cancer	0.000294	0.004	CcSEcCtD
Diphenhydramine—Asthenia—Carmustine—brain cancer	0.000292	0.00397	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP2C9—brain cancer	0.000289	0.0517	CrCbGaD
Diphenhydramine—Paraesthesia—Etoposide—brain cancer	0.000283	0.00385	CcSEcCtD
Diphenhydramine—Asthenia—Temozolomide—brain cancer	0.000282	0.00384	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—brain cancer	0.00028	0.00381	CcSEcCtD
Diphenhydramine—Diarrhoea—Carmustine—brain cancer	0.000278	0.00379	CcSEcCtD
Diphenhydramine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000278	0.00975	CbGpPWpGaD
Diphenhydramine—Decreased appetite—Etoposide—brain cancer	0.000274	0.00372	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—brain cancer	0.000271	0.00369	CcSEcCtD
Diphenhydramine—Dizziness—Carmustine—brain cancer	0.000269	0.00366	CcSEcCtD
Diphenhydramine—Constipation—Etoposide—brain cancer	0.000269	0.00366	CcSEcCtD
Diphenhydramine—Diarrhoea—Temozolomide—brain cancer	0.000269	0.00366	CcSEcCtD
Diphenhydramine—Phenytoin—CYP2C9—brain cancer	0.000265	0.0474	CrCbGaD
Diphenhydramine—CYP2C18—Biological oxidations—CYP2C9—brain cancer	0.000262	0.00921	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000262	0.00919	CbGpPWpGaD
Diphenhydramine—Dizziness—Temozolomide—brain cancer	0.00026	0.00354	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—brain cancer	0.000259	0.00353	CcSEcCtD
Diphenhydramine—Vomiting—Carmustine—brain cancer	0.000259	0.00352	CcSEcCtD
Diphenhydramine—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	0.000258	0.00908	CbGpPWpGaD
Diphenhydramine—Tamoxifen—ESR2—brain cancer	0.000258	0.0461	CrCbGaD
Diphenhydramine—Rash—Carmustine—brain cancer	0.000257	0.00349	CcSEcCtD
Diphenhydramine—Dermatitis—Carmustine—brain cancer	0.000256	0.00349	CcSEcCtD
Diphenhydramine—Headache—Carmustine—brain cancer	0.000255	0.00347	CcSEcCtD
Diphenhydramine—Vomiting—Temozolomide—brain cancer	0.00025	0.0034	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—brain cancer	0.00025	0.0034	CcSEcCtD
Diphenhydramine—Rash—Temozolomide—brain cancer	0.000248	0.00337	CcSEcCtD
Diphenhydramine—Dermatitis—Temozolomide—brain cancer	0.000248	0.00337	CcSEcCtD
Diphenhydramine—CHRM2—endocrine gland—brain cancer	0.000248	0.0194	CbGeAlD
Diphenhydramine—Headache—Temozolomide—brain cancer	0.000246	0.00335	CcSEcCtD
Diphenhydramine—CHRM2—head—brain cancer	0.000244	0.0192	CbGeAlD
Diphenhydramine—SLC22A1—endocrine gland—brain cancer	0.000243	0.0191	CbGeAlD
Diphenhydramine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000243	0.00852	CbGpPWpGaD
Diphenhydramine—Nausea—Carmustine—brain cancer	0.000242	0.00329	CcSEcCtD
Diphenhydramine—SLC22A1—head—brain cancer	0.00024	0.0188	CbGeAlD
Diphenhydramine—Nausea—Temozolomide—brain cancer	0.000234	0.00318	CcSEcCtD
Diphenhydramine—HRH1—telencephalon—brain cancer	0.000227	0.0178	CbGeAlD
Diphenhydramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000226	0.00794	CbGpPWpGaD
Diphenhydramine—Asthenia—Etoposide—brain cancer	0.000226	0.00307	CcSEcCtD
Diphenhydramine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000223	0.00784	CbGpPWpGaD
Diphenhydramine—CHRM2—central nervous system—brain cancer	0.000223	0.0175	CbGeAlD
Diphenhydramine—SLC22A1—central nervous system—brain cancer	0.000219	0.0172	CbGeAlD
Diphenhydramine—SLC22A5—pituitary gland—brain cancer	0.000218	0.0171	CbGeAlD
Diphenhydramine—Diarrhoea—Etoposide—brain cancer	0.000215	0.00293	CcSEcCtD
Diphenhydramine—Trimipramine—CYP2C9—brain cancer	0.000211	0.0378	CrCbGaD
Diphenhydramine—SLC22A5—medulla oblongata—brain cancer	0.000211	0.0165	CbGeAlD
Diphenhydramine—PTGS1—telencephalon—brain cancer	0.00021	0.0165	CbGeAlD
Diphenhydramine—Dizziness—Etoposide—brain cancer	0.000208	0.00283	CcSEcCtD
Diphenhydramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000208	0.00731	CbGpPWpGaD
Diphenhydramine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000205	0.00721	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000204	0.00716	CbGpPWpGaD
Diphenhydramine—Promethazine—CYP2C9—brain cancer	0.000204	0.0364	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2C9—brain cancer	0.000202	0.0362	CrCbGaD
Diphenhydramine—Doxepin—CYP2C9—brain cancer	0.000202	0.036	CrCbGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000201	0.00705	CbGpPWpGaD
Diphenhydramine—Methadone—CYP2C9—brain cancer	0.0002	0.0359	CrCbGaD
Diphenhydramine—Vomiting—Etoposide—brain cancer	0.0002	0.00272	CcSEcCtD
Diphenhydramine—Rash—Etoposide—brain cancer	0.000198	0.0027	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—brain cancer	0.000198	0.0027	CcSEcCtD
Diphenhydramine—Headache—Etoposide—brain cancer	0.000197	0.00268	CcSEcCtD
Diphenhydramine—CYP2D6—brainstem—brain cancer	0.000195	0.0153	CbGeAlD
Diphenhydramine—CYP2B6—gonad—brain cancer	0.000194	0.0152	CbGeAlD
Diphenhydramine—SLC22A5—midbrain—brain cancer	0.000192	0.0151	CbGeAlD
Diphenhydramine—SLC22A5—spinal cord—brain cancer	0.000188	0.0147	CbGeAlD
Diphenhydramine—CYP2C19—endocrine gland—brain cancer	0.000187	0.0147	CbGeAlD
Diphenhydramine—Nausea—Etoposide—brain cancer	0.000187	0.00254	CcSEcCtD
Diphenhydramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000183	0.00644	CbGpPWpGaD
Diphenhydramine—Promazine—CYP2C9—brain cancer	0.000179	0.032	CrCbGaD
Diphenhydramine—CHRM2—brain—brain cancer	0.000177	0.0139	CbGeAlD
Diphenhydramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000176	0.00619	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—HES5—brain cancer	0.000174	0.00612	CbGpPWpGaD
Diphenhydramine—SLC22A1—brain—brain cancer	0.000174	0.0136	CbGeAlD
Diphenhydramine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000174	0.00611	CbGpPWpGaD
Diphenhydramine—CYP2D6—telencephalon—brain cancer	0.000173	0.0136	CbGeAlD
Diphenhydramine—PTGS1—pituitary gland—brain cancer	0.000171	0.0134	CbGeAlD
Diphenhydramine—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000169	0.00593	CbGpPWpGaD
Diphenhydramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000169	0.00592	CbGpPWpGaD
Diphenhydramine—Amitriptyline—CYP2C9—brain cancer	0.000156	0.0279	CrCbGaD
Diphenhydramine—CYP1A2—endocrine gland—brain cancer	0.000153	0.012	CbGeAlD
Diphenhydramine—SLC22A5—cerebellum—brain cancer	0.000149	0.0117	CbGeAlD
Diphenhydramine—PTGS1—spinal cord—brain cancer	0.000147	0.0116	CbGeAlD
Diphenhydramine—CYP2B6—endocrine gland—brain cancer	0.000147	0.0115	CbGeAlD
Diphenhydramine—CYP2C9—endocrine gland—brain cancer	0.000145	0.0114	CbGeAlD
Diphenhydramine—CYP2B6—head—brain cancer	0.000145	0.0114	CbGeAlD
Diphenhydramine—HRH1—endocrine gland—brain cancer	0.000143	0.0112	CbGeAlD
Diphenhydramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000143	0.00502	CbGpPWpGaD
Diphenhydramine—HRH1—head—brain cancer	0.000141	0.0111	CbGeAlD
Diphenhydramine—CHRM2—GPCRs, Other—SMO—brain cancer	0.000135	0.00475	CbGpPWpGaD
Diphenhydramine—PTGS1—endocrine gland—brain cancer	0.000133	0.0104	CbGeAlD
Diphenhydramine—CYP2B6—central nervous system—brain cancer	0.000132	0.0104	CbGeAlD
Diphenhydramine—PTGS1—head—brain cancer	0.000131	0.0103	CbGeAlD
Diphenhydramine—HRH1—central nervous system—brain cancer	0.000129	0.0101	CbGeAlD
Diphenhydramine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000129	0.00453	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000127	0.00446	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000122	0.00428	CbGpPWpGaD
Diphenhydramine—SLC22A5—brain—brain cancer	0.000121	0.00948	CbGeAlD
Diphenhydramine—PTGS1—central nervous system—brain cancer	0.00012	0.00938	CbGeAlD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	0.000114	0.00402	CbGpPWpGaD
Diphenhydramine—CYP2D6—endocrine gland—brain cancer	0.000109	0.00855	CbGeAlD
Diphenhydramine—CYP2D6—head—brain cancer	0.000108	0.00844	CbGeAlD
Diphenhydramine—CYP2B6—brain—brain cancer	0.000105	0.00823	CbGeAlD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000103	0.00363	CbGpPWpGaD
Diphenhydramine—HRH1—brain—brain cancer	0.000103	0.00804	CbGeAlD
Diphenhydramine—CYP2D6—central nervous system—brain cancer	9.83e-05	0.00771	CbGeAlD
Diphenhydramine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.74e-05	0.00342	CbGpPWpGaD
Diphenhydramine—CYP2D6—cerebellum—brain cancer	9.6e-05	0.00753	CbGeAlD
Diphenhydramine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.6e-05	0.00337	CbGpPWpGaD
Diphenhydramine—PTGS1—brain—brain cancer	9.49e-05	0.00744	CbGeAlD
Diphenhydramine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.4e-05	0.0033	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.96e-05	0.00315	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.83e-05	0.0031	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—PTCH2—brain cancer	7.98e-05	0.0028	CbGpPWpGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	7.89e-05	0.00277	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	7.86e-05	0.00276	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—PTCH2—brain cancer	7.85e-05	0.00276	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.83e-05	0.00275	CbGpPWpGaD
Diphenhydramine—CYP2D6—brain—brain cancer	7.8e-05	0.00612	CbGeAlD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	7.67e-05	0.00269	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.59e-05	0.00267	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.48e-05	0.00263	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—ESR2—brain cancer	7.42e-05	0.00261	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	7.14e-05	0.00251	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	7.03e-05	0.00247	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	7e-05	0.00246	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	7e-05	0.00246	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	6.95e-05	0.00244	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—OR4C12—brain cancer	6.88e-05	0.00242	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—OR14C36—brain cancer	6.88e-05	0.00242	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.48e-05	0.00228	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—OR14C36—brain cancer	6.35e-05	0.00223	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—OR4C12—brain cancer	6.35e-05	0.00223	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—OR4C12—brain cancer	6.25e-05	0.0022	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—OR14C36—brain cancer	6.25e-05	0.0022	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	5.98e-05	0.0021	CbGpPWpGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	5.98e-05	0.0021	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—HES1—brain cancer	5.76e-05	0.00202	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	5.69e-05	0.002	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	5.63e-05	0.00198	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.74e-05	0.00167	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.51e-05	0.00159	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP2C9—brain cancer	4.48e-05	0.00157	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	4.41e-05	0.00155	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—APC—brain cancer	4.41e-05	0.00155	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—SHH—brain cancer	4.11e-05	0.00144	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTCH2—brain cancer	4.09e-05	0.00144	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.07e-05	0.00143	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—SHH—brain cancer	4.04e-05	0.00142	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTCH2—brain cancer	4.03e-05	0.00142	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—PTCH1—brain cancer	3.9e-05	0.00137	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—SMO—brain cancer	3.9e-05	0.00137	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—PTCH1—brain cancer	3.83e-05	0.00135	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—SMO—brain cancer	3.83e-05	0.00135	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—BSG—brain cancer	3.81e-05	0.00134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—OR4C12—brain cancer	3.75e-05	0.00132	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—OR14C36—brain cancer	3.75e-05	0.00132	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.74e-05	0.00131	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—OR4C12—brain cancer	3.69e-05	0.0013	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—OR14C36—brain cancer	3.69e-05	0.0013	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.54e-05	0.00124	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ABR—brain cancer	3.54e-05	0.00124	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ABR—brain cancer	3.48e-05	0.00122	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.46e-05	0.00121	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.3e-05	0.00116	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—IDH1—brain cancer	3.28e-05	0.00115	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ABR—brain cancer	3.21e-05	0.00113	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DTX2—brain cancer	3.19e-05	0.00112	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.18e-05	0.00112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ABR—brain cancer	3.16e-05	0.00111	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DTX2—brain cancer	3.14e-05	0.0011	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.11e-05	0.00109	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.11e-05	0.00109	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP2C9—brain cancer	2.97e-05	0.00105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.91e-05	0.00102	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.89e-05	0.00101	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP2C9—brain cancer	2.89e-05	0.00101	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP2C9—brain cancer	2.77e-05	0.000974	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.73e-05	0.00096	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ENO2—brain cancer	2.59e-05	0.00091	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.54e-05	0.000893	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—BSG—brain cancer	2.53e-05	0.000889	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.49e-05	0.000876	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—BSG—brain cancer	2.46e-05	0.000863	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTCH2—brain cancer	2.42e-05	0.00085	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTCH2—brain cancer	2.38e-05	0.000836	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	2.37e-05	0.000834	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—BSG—brain cancer	2.36e-05	0.000828	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HES5—brain cancer	2.34e-05	0.000823	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HES5—brain cancer	2.3e-05	0.00081	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STRADA—brain cancer	2.27e-05	0.000799	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	2.24e-05	0.000787	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STRADA—brain cancer	2.24e-05	0.000786	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.2e-05	0.000774	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	2.2e-05	0.000774	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—IDH1—brain cancer	2.18e-05	0.000764	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.13e-05	0.000748	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—IDH1—brain cancer	2.11e-05	0.000742	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—SHH—brain cancer	2.11e-05	0.000741	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—SHH—brain cancer	2.08e-05	0.000729	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TRPC6—brain cancer	2.03e-05	0.000714	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—IDH1—brain cancer	2.03e-05	0.000712	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	2e-05	0.000703	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTCH1—brain cancer	2e-05	0.000702	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—SMO—brain cancer	2e-05	0.000702	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—SMO—brain cancer	1.97e-05	0.000691	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	1.97e-05	0.000691	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ABR—brain cancer	1.9e-05	0.000667	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—BSG—brain cancer	1.87e-05	0.000658	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ABR—brain cancer	1.87e-05	0.000656	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GLI2—brain cancer	1.83e-05	0.000644	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GLI2—brain cancer	1.8e-05	0.000634	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.8e-05	0.000632	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GLI1—brain cancer	1.72e-05	0.000605	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ENO2—brain cancer	1.72e-05	0.000604	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.72e-05	0.000604	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GLI1—brain cancer	1.7e-05	0.000596	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—VAV1—brain cancer	1.68e-05	0.000589	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ENO2—brain cancer	1.67e-05	0.000586	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.67e-05	0.000585	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	1.65e-05	0.00058	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SUFU—brain cancer	1.63e-05	0.000574	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—IDH1—brain cancer	1.61e-05	0.000566	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SUFU—brain cancer	1.61e-05	0.000565	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ENO2—brain cancer	1.6e-05	0.000563	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GFAP—brain cancer	1.58e-05	0.000554	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GFAP—brain cancer	1.55e-05	0.000545	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.53e-05	0.000538	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—VAV1—brain cancer	1.52e-05	0.000535	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—VAV1—brain cancer	1.5e-05	0.000527	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HEY1—brain cancer	1.49e-05	0.000525	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HEY1—brain cancer	1.47e-05	0.000516	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DLL1—brain cancer	1.47e-05	0.000515	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DLL1—brain cancer	1.44e-05	0.000506	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—BSG—brain cancer	1.42e-05	0.000497	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—BSG—brain cancer	1.3e-05	0.000457	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.3e-05	0.000456	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—BSG—brain cancer	1.29e-05	0.000453	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ENO2—brain cancer	1.27e-05	0.000447	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SHH—brain cancer	1.25e-05	0.000438	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SHH—brain cancer	1.23e-05	0.000431	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—IDH1—brain cancer	1.22e-05	0.000428	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TRPC6—brain cancer	1.2e-05	0.000422	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CG—brain cancer	1.19e-05	0.000417	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TRPC6—brain cancer	1.18e-05	0.000415	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SMO—brain cancer	1.18e-05	0.000415	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTCH1—brain cancer	1.18e-05	0.000415	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SMO—brain cancer	1.16e-05	0.000408	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTCH1—brain cancer	1.16e-05	0.000408	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—IDH1—brain cancer	1.12e-05	0.000393	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—IDH1—brain cancer	1.11e-05	0.00039	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—BSG—brain cancer	1.1e-05	0.000388	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.07e-05	0.000374	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.05e-05	0.000368	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.91e-06	0.000348	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	9.67e-06	0.00034	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ENO2—brain cancer	9.62e-06	0.000338	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	9.52e-06	0.000334	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—IDH1—brain cancer	9.49e-06	0.000333	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH2—brain cancer	9.44e-06	0.000332	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	9.29e-06	0.000326	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.04e-06	0.000318	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VAV1—brain cancer	9e-06	0.000316	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VAV1—brain cancer	8.86e-06	0.000311	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ENO2—brain cancer	8.85e-06	0.000311	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ENO2—brain cancer	8.77e-06	0.000308	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CG—brain cancer	7.89e-06	0.000277	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HES1—brain cancer	7.74e-06	0.000272	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.72e-06	0.000271	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CG—brain cancer	7.66e-06	0.000269	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HES1—brain cancer	7.62e-06	0.000268	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ENO2—brain cancer	7.5e-06	0.000263	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—brain cancer	7.5e-06	0.000263	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—brain cancer	7.38e-06	0.000259	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.37e-06	0.000259	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—brain cancer	7.35e-06	0.000258	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	7.25e-06	0.000255	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—brain cancer	7.16e-06	0.000251	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—brain cancer	7.04e-06	0.000247	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—brain cancer	6.81e-06	0.000239	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—brain cancer	6.7e-06	0.000235	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS2—brain cancer	6.47e-06	0.000227	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS2—brain cancer	6.37e-06	0.000224	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—brain cancer	5.84e-06	0.000205	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.71e-06	0.000201	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—brain cancer	5.71e-06	0.000201	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	5.62e-06	0.000198	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—brain cancer	5.62e-06	0.000198	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—brain cancer	5.21e-06	0.000183	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—brain cancer	5.12e-06	0.00018	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RELA—brain cancer	4.47e-06	0.000157	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—brain cancer	4.44e-06	0.000156	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.41e-06	0.000155	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RELA—brain cancer	4.39e-06	0.000154	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.37e-06	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.06e-06	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.03e-06	0.000141	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—brain cancer	4.02e-06	0.000141	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—brain cancer	3.96e-06	0.000139	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—brain cancer	3.92e-06	0.000138	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.88e-06	0.000136	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—brain cancer	3.86e-06	0.000136	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.82e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.44e-06	0.000121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—brain cancer	3.42e-06	0.00012	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—brain cancer	3.38e-06	0.000119	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.36e-06	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—brain cancer	3.33e-06	0.000117	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—brain cancer	3.14e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—brain cancer	3.09e-06	0.000109	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—brain cancer	3.08e-06	0.000108	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—brain cancer	3.03e-06	0.000106	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—brain cancer	2.58e-06	9.07e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—brain cancer	2.54e-06	8.93e-05	CbGpPWpGaD
